AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

NASDAQ STOCKS IN THE NEWS.(B)

Investor's Business Daily

| July 01, 2005 | COPYRIGHT 2005 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

CENTER FINANCIAL CORP CA (CLFC)Grp 128$24.83

11.1M Shares97 Comp. Rating98 EPSRS 93ROE 18%

HOLDING COMPANY FOR CENTER BANK SERVING SOUTHERN CALIFORNIA THROUGH 12 FULL-SERVICE BRANCH OFFICES.

+23% Ann. EPS Gro PE 24 Avg. Daily Vol 134,900 Debt 20%

Last Qtr Eps +65% Prior Qtr +44% Last Qtr Sales +45%

3 Qtrs EPS 15%

Eps Due 7/26

Related articles from newspapers, magazines, journals, and more
AUTOZONE 1ST QTR EPS UP 27%, COMPARABLE STORE SALES UP 8%
Press release article from: PR Newswire December 8, 1994 700+ words
MEMPHIS, Tenn., Dec. 8 /PRNewswire/ -- J.R. Hyde III, chairman and chief executive of AutoZone, Inc. (NYSE: AZO), announced record results for AutoZone's first quarter of fiscal 1995. AutoZone's net income for the 12 weeks ended November 19, 1994, increased 25% to $27.6 million from $22.0 million
AUTOZONE 1ST QTR EPS UP 30 PERCENT, COMPARABLE STORE SALES UP 14 PERCENT; 31...
Press release article from: PR Newswire December 7, 1993 700+ words
MEMPHIS, Tenn., Dec. 7 /PRNewswire/ -- J.R. Hyde, III, chairman and chief executive of AutoZone, Inc. (NYSE: AZO), announced record results for AutoZone's first quarter of fiscal 1994. AutoZone's net income for the 12 weeks ended Nov. 20, 1993, increased 29 percent to $22.0 million from $17.1
GlaxoSmithKline 4th-qtr EPS rises 15%.(earnings per share)(Brief Article)
Newspaper article from: Pharma Marketletter February 14, 2005 700+ words
GlaxoSmithKline, the world's second-largest drugmaker, reported a 17% rise in fourth-quarter 2004 pretax profit at L1.39 billion ($2.53 billion) at constant exchange rates and earnings per share up 15% at 16.8 pence. Revenues for the quarter rose 3% at CER to L5.33 billion, but were down 1% in
Wyeth reaffirms 1st qtr EPS guidance.(Brief Article)
Newspaper article from: Pharma Marketletter April 4, 2005 700+ words
US pharmaceutical major Wyeth has reaffirmed its guidance for the first quarter of 2005, noting a significant discrepancy with the Thomson First Call mean analysts estimate of $0.67 diluted earnings per share. Wyeth predicts that, given the strong performance of a number of its key brands,
Dendrite's 2nd-qtr EPS rises 26%.
Newspaper article from: Pharma Marketletter August 18, 2003 700+ words
Dendrite International has announced solid second-quarter 2003 diluted earnings of $0.14 per share, up 26%. Generally-accepted accounting procedure diluted earnings per share includes approximately $0.02 in other charges, including amortization of definite intangibles arising from acquisitions and
ORNDA REPORTS FIRST QTR EPS OF $0.44 ON REVENUE GROWTH OF 29.1%.
Press release article from: Business Wire January 7, 1997 700+ words
NASHVILLE, TennBUSINESS WIREJan. 7, 1997--OrNda HealthCorp (NYSE:ORN) today reported that net income applicable to common shares for the three months ended November 30, 1996, increased 34.9% to $26.4 million from $19.6 million in the first quarter of last year. Earnings per share rose to $0.44 for
J&J 4th-qtr EPS up 35%, sales rise 20%.(Brief Article)
Newspaper article from: Pharma Marketletter January 26, 2004 700+ words
US health care major Johnson & Johnson has reported solid growth in the fourth quarter of 2003, fuelled by prescription drugs and medical devices, and chief executive William Weldon pointed out the firm has once again delivered double-digit increases in sales and earnings. Total turnover for
RHS ANNOUNCES 3RD QTR EPS OF $.22.
Press release article from: Business Wire October 24, 1996 700+ words
TUSTIN, CalifBUSINESS WIREOct. 24, 1996--Regency Health Services, Inc. (NYSE:RHS) today announced earnings per share, prior to an extraordinary charge for early extinguishment of debt, of $.22 for the third quarter ended September 30, 1996. This is compared to earnings of $.22 per share for the
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA